公开(公告)号：US20220274965A1

公开(公告)日：2022-09-01

申请号：US17631257

申请日：2020-07-30

Applicant: GRIFFITH UNIVERSITY

Inventor： Mark Von Itzstein ,  Ibrahim El-Deeb ,  Larissa Heilig ,  Patrice Guillon

IPC: C07D405/04 ,  C07D405/14 ,  C07D471/04 ,  C07D491/056 ,  C07D495/04

Abstract: The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I) In which R3 is selected from the group consisting of optionally substituted N-linked naphthotriazole, optionally substituted N-linked indazole, and certain N-linked triazoles. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection, and pharmaceutical compositions comprising the compounds.